The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 19, 2019

Filed:

Jan. 06, 2017
Applicant:

Colorado State University Research Foundation, Fort Collins, CO (US);

Inventors:

Steven W. Dow, Littleton, CO (US);

Daniel P. Regan, Fort Collins, CO (US);

Amanda Guth, Fort Collins, CO (US);

Leah Mitchell, San Diego, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/405 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61K 45/06 (2006.01); A61K 31/404 (2006.01); A61K 31/4178 (2006.01); A61K 31/437 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0005 (2013.01); A61K 31/404 (2013.01); A61K 31/4178 (2013.01); A61K 31/437 (2013.01); A61K 39/39 (2013.01); A61K 45/06 (2013.01); A61K 2039/55511 (2013.01);
Abstract

Provided are methods of enhancing an immune response and methods for reducing the recruitment of monocytes to a lymph node by administering to an individual an angiotensin II receptor blocker or a compound of Formula (I) in conjunction with an antigen. The invention also provides relate methods for amplifying vaccine immunity by administering to an individual an angiotensin II receptor blocker or a compound of Formula (I) in conjunction with an vaccine. The invention also provides related methods of inhibiting tumor growth and metastasis by administering to an individual with cancer an angiotensin II receptor blocker or a compound of Formula (I) in conjunction with an anti-tumor preparation. In addition, related compositions comprising an ARB or a compound of Formula (I) and an antigen, vaccine, or anti-tumor preparation are provided.


Find Patent Forward Citations

Loading…